跳至主要内容
临床试验/NCT01901575
NCT01901575已完成4 期

Remifentanil IV PCA for Ablation of Idiopathic Ventricular Tachycardia

NYU Langone Health1 个研究点 分布在 1 个国家目标入组 16 人开始时间: 2011年7月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
16
试验地点
1
主要终点
Inhibition of Idiopathic Ventricular Tachycardia

研究概览

简要总结

Determine effects of remifentanil conscious sedation in patients undergoing Electrophysiological (EP) studies for the ablation of idiopathic ventricular tachycardia and/or persistent frequent premature ventricular contractions (PVCs) of non-ischemic origin

详细描述

The purpose of the study is to determine the effects of remifentanil conscious sedation in patients undergoing Electrophysiological (EP) studies for the ablation of idiopathic ventricular tachycardia and/or persistent frequent PVCs of non-ischemic origin.

Remifentanil is an analgesic- synthetic opiate with an very short half life. It is rapidly broken down by enzymes in the blood and is ideally suited for continuous sedation. The effect is practically eliminated within 5 minutes after the intravenous sedation is stopped.

You are being asked to participate in this study because you are already scheduled to undergo EP studies under the care of your cardiologist for the ablation of idiopathic ventricular tachycardia and/or persistent frequent PVCs of non-ischemic origin.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients scheduled to undergo EP studies for the ablation of idiopathic ventricular tachycardia and/or persistent frequent PVCs of non-ischemic origin
  • Patients between 18 and 65

排除标准

  • ASA 4 and 5
  • Age 18 and 65

研究组 & 干预措施

Remifentanil IV PCA

Experimental

patients with PVC's prior to administration of remifentanil

干预措施: Remifentanil (Drug)

结局指标

主要结局

Inhibition of Idiopathic Ventricular Tachycardia

时间窗: duration of the procedure or until the presence of PVC's was no longer required for the cardiologist to complete the ablation, average 2 hours

observation of the anesthetic effect on the inhibition of the ventricular tachycardia in patients undergoing radio-frequency ablation of idiopathic ventricular tachycardia. Patients were continuously monitored for presence of PVC's. Every 15 minutes patient's heart rhythm (EKG) was documented on the anesthetic record. Presence of PVC's of the same morphology was confirmed by the cardiologist performing the ablation.

PVC Suppression With Remifentanil Sedation

时间窗: duration of the operative procedure, average 2 hours

1 observed suppression of PVC's (PVC's of the same morphology are no longer observed during any 15 minute recording interval) 0 no suppression

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验